|
|
A new report released Wednesday finds that 15 million babies worldwide are born prematurely each year. For any hope of prevention, preterm birth needs to raise its PR profile.
Percent lower rate of premature delivery in high-risk women who received a vaginal progesterone gel during pregnancy, compared with those who got a placebo. The hormone treatment also reduced the risk of breathing problems in babies. The mothers in the study had short cervixes, a known cause of preterm birth. [via Reuters]
The saga of the prematurity-prevention drug Makena and the outrage over its pricing continues: on Friday, the maker of the drug, a subsidiary of KV Pharmaceutical, announced it would reduce its price 55%, from $1,500 to $690 per dose.
KV Pharmaceutical’s Makena, a new brand of an old drug to prevent premature birth, went on sale last week at an exponentially increased price — going from about $10-$20 per dose to $1,500, and inviting widespread criticism and scrutiny.
In the wake of growing public outrage over the 150-fold increase in the price of a drug used to prevent premature birth — newly approved Makena, a form of progesterone, will cost $1,500 a dose compared with $10 for existing versions — Senator Sherrod Brown (D-Ohio) has sent a letter to manufacturer KV Pharmaceuticals asking [...]
The cost of a drug used to prevent premature birth in high-risk mothers will rise from around $10 per dose to $1,500, now that the FDA has approved a branded version of the medication.
Premature births are on the rise in the U.S., as my colleague Laura Blue reported recently, and despite all of the health care dollars being spent to usher preemies safely into the world—some $26 billion annually—too often they number among the 30,000 babies under a year old who die every year in this country. It’s [...]
Tired of your mindless treadmill routine and all that running leading nowhere? Consider mixing up your fitness plan, with more and more gyms offering unique classes for workouts that are effective — and fun.
